Repurposing flumazenil for pre-hospital intramuscular treatment of coma due to recreational drug overdose;

Project Details

Description

01 October 2023 (54 months); DPFS MRC Biomedical Catalyst Reference: MR/X030237/1; £2,853,402. Co-Applicant (CI Professor Michael Eddleston)
AcronymRUFUS
StatusActive
Effective start/end date1/10/2331/03/28

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.